Rothschild Investment LLC Neogenomics Inc Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of NEO stock, worth $1,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 155
29.03%
Holding current value
$1,069
Previous $2.55 Million
59.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$191 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$138 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$63.5 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$59.9 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$59.8 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.22B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...